Genetic Prognostic Testing for Adolescent Idiopathic Scoliosis

Will a genetic test change scoliosis treatment?

This course has expired. You may still view the lesson, however, no credit will be issued.

Genetic prognostic testing has the potential to transform the treatment of AIS. Doctors Newton, Ogilvie, Shah, and Shufflebarger explain the science and discuss treatment implications.

Release Date: August 10, 2009
Expiration Date: August 10, 2010

Faculty

  • Peter O. Newton, MD Co-Chair About

    Associate Clinical Professor
    Department of Orthopaedic Surgery
    University of California, San Diego
     

    Doctor Peter Newton is Associate Clinical Professor, Department of Orthopaedic Surgery at the University of California, San Diego, CA. Board certified, Dr. Newton is a Pediatric Orthopedic Surgeon at the Pediatric Orthopedic and Scoliosis Center at Children's Specialists of San Diego. In addition, he is Chief of Orthopedic Research at Rady Children's Hospital and Health Center, also in San Diego.  Read More

  • James W. Ogilvie, MD Co-Chair About

    Professor
    Department of Orthopaedic Surgery

    University of Utah
    Salt Lake City, UT
     

    Doctor James Ogilvie is a board certified orthopaedic surgeon. In addition to private practice, Dr. Ogilvie is Professor, Department of Orthopaedic Surgery, at the University of Utah in Salt Lake City and Professor Emeritus, Department of Orthopaedic Surgery, at the University of Minnesota in Minneapolis, MN. He is Staff Surgeon / Attending Staff at Shriners Hospital Intermountain Unit in Salt Lake City.  Read More

  • Suken A. Shah, MD Co-Chair About

    Attending Pediatric Orthopaedic Surgeon
    Co-Director, Spine and Scoliosis Service

     

    Alfred I. duPont Hospital for Children
    Department of Orthopaedics
    Wilmington, DE

    Doctor Suken Shah is an Attending Pediatric Orthopaedic Surgeon and Co-Director of Spine and Scoliosis Service at the Alfred I. duPont Hospital for Children, Department of Orthopaedics in Wilmington, DE. He also is an Assistant Professor of Orthopaedic Surgery at Jefferson Medical College of Thomas Jefferson University in Philadelphia, PA.  Read More

  • Harry L. Shufflebarger, MD Co-Chair About

    Clinical Professor of Orthopaedics and Rehabilitation

    Miami Children's Hospital
    Miami, FL USA

    Doctor Shufflebarger is Clinical Professor of Orthopaedics and Rehabilitation at the University of Miami School of Medicine. He holds a hospital appointment at Miami Children's Hospital as Chief of the Division of Spinal Surgery, Department of Orthopaedic Surgery and holds a secondary appointment in the Department of Neurosurgery.  Read More

Target Audience

This online continuing education program is intended for orthopaedic and neurological surgeons, residents, and fellows who include spinal surgery in their practices.

Educational Objectives

  • Discuss the role and impact of genetic testing in adolescent idiopathic scoliosis including evidence-based medicine based on genotypes.
  • Discuss the challenges spine surgeons face when evaluating scoliosis, including familial relationships and treatment bias, incidence of and predicting progression, and current indications for genetic testing.
  • Describe the relationship of scoliosis to growth, including practice methods to evaluate skeletal maturity.

Course Completion Time

Based upon trials, the estimated time to complete this program is 1 hour.

Sponsorship

This activity is sponsored by Medical Education Resources, Inc., a non-profit medical education company. BroadWater, a Vertical Health, LLC company was selected to manage program development logistics.

Educational Grant

This activity received a restricted educational grant from DePuy Spine, Inc., a Johnson and Johnson Company.

Physician Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources and BroadWater. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Medical Education Resources (MER) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/ authors participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations.

Faculty Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME guidelines, the financial and significant relationships to this program are listed below.

Peter O. Newton, MD has indicated the following relevant financial relationships: Axial Biotech, Inc.: Grants/Research Support DePuy Spine: Consultant, Grants/Research Support, Other Financial or Material Support

James W. Ogilvie, MD has indicated the following relevant financial relationships: Axial Biotech, Inc.: Consultant, Stock/Shareholder

Suken A. Shah, MD has indicated the following relevant financial relationships: Axial Biotech, Inc.: Grants/Research Support and DePuy Spine: Consultant, Grants/Research Support, Other Financial or Material Support  

Harry L. Shufflebarger, MD has indicated the following relevant financial relationships: DePuy: Consultant; Speakers Bureau, Financial or Material Support.

Staff Disclosure

Jeremy Longhurst, Susan Spinasanta: Nothing to disclose.

The staff at MER has nothing to disclose.

Advisor/Staff Disclosures
Jason M. Highsmith, MD: Speakers Bureau: Boston Scientific, Globus Medical

Disclaimer

The content and views presented in this educational activity are those of the
faculty and do not necessarily reflect those of Medical Education Resources.

A restricted educational grant in support of this program was provided by:
DePuy Spine, Inc.

Off-Label/Investigational Use

It should be noted that specific medicines and medical devices discussed or referred to in this program may not yet be specifically cleared by the FDA for use in the United States. It is emphasized that package inserts must be referred to for labeling limitations for products used in the United States.

Software Requirements